Related Experiment Video
Updated: May 31, 2026

Whole Blood Assay with Dual Co-Stimulation for Antigen-Specific Analysis of Host Immunity to Fungal and Viral Pathogens
Published on: September 20, 2024
Complement activation in patients with post-acute sequelae after SARS-CoV-2 infection
Madlene Holmqvist1,2, Dick J Sjöström3, Katherine Carlson1
1Division of Infection Medicine, Department of Clinical Sciences, Lund University, Lund, Sweden.
Introduction:
Post-acute sequelae of SARS-CoV-2 (PASC) may develop after SARS-CoV-2 infection and cause a wide range of symptoms that can persist for years. Several pathophysiological mechanisms have been proposed, including dysregulation of the complement system.
Methods:
In this study, we analysed markers of complement activation in a cohort of patients with PASC, up to 33 months after the initial infection. We measured the complement activation markers C3bc, C3bBbP and TCC in 38 PASC patients with an initial mild COVID-19 infection, 10 PASC patients with an initial severe COVID-19 infection and 80 control subjects who had recovered completely after a COVID-19 infection.
Results:
Although the patients with an acute mild SARS-CoV-2 infection had a trend towards more severe PASC, we could not find any significant differences in complement activation markers between these patients and controls.
Conclusion:
We could not find convincing evidence of activation of the complement system in PASC patients.
Related Concept Videos
Complement System
Coronavirus
Acute Inflammation II: Cellular Phase
Hypersensitivity Reactions: Immune-Complex Reactions
Pneumonia II: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
